Max Healthcare Institute Limited is an India-based healthcare company with a market capitalisation of Rs. 35,729.35 crore as of April 5, 2022. It owns and operates hospital chains across Delhi, National Capital Region (NCR), North India, and Mumbai. The company was incorporated on June 18, 2001, and its revenue touched Rs. 2,505 crore in the financial year 2021-22. Max Healthcare shares are listed on the Bombay Stock Exchange (BSE) as well as the National Stock Exchange (NSE) under the number 543220 and scrip code MAXHEALTH, respectively.
Max Healthcare Limited is an Indian company that runs a chain of hospitals that specialise in providing treatment for cancer, oncology, neurosciences, cardiac sciences, orthopaedics, liver transplant, kidney transplant, bone marrow transplant, nephrology, and laparoscopic surgery, among others. The company also provides pathology and diagnostic services to its patients through a variety of channels, including self-owned and third-party diagnostic centres. The majority of Max Healthcare hospitals are located in Delhi, the National Capital Region (NCR), northern parts of India, and western Mumbai.
The company was founded in 2000 and its first hospital was opened in the same year in South Delhi’s Panchsheel Park. It opened two more hospitals in 2002 in Northwest Delhi and Eastern Delhi. In 2011, Max Healthcare Limited signed a public-private partnership agreement with the government of Punjab to set up two hospitals in Mohali and Bathinda. It witnessed acquisitions and mergers with several hospitals during the process, including Pushpanjali Crosslay Hospital in Vaishali, Saket City Hospital in Saket, Radiant Lifecare, and the iconic Nanavati Hospital in Mumbai, and soon became the second-largest healthcare company in India in terms of revenues. The total number of employees of this company stood at 3,783 in 2020. The Managing Director of the company, Abhay Soi, holds 23.1% shares in the company, other promoters 37.54%, FII investors 16.67%, public investors 6.97%, and 15.58% are invested in mutual funds.
As of April 5, 2022, Max Healthcare’s share price closed at Rs. 369.40 at the NSE. The 52-week high for Max Health share is Rs. 458.05 and the 52-week low is Rs. 212.00. Max Healthcare shares have provided one-year returns of 61.06%.
Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code :07730), BSE Ltd (Member Code :103) and Member of Multi Commodity Exchange of India Ltd. (Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.
Max Healthcare Institute share price as on 27 Feb 2026 is Rs. 1091.95. Over the past 6 months, the Max Healthcare Institute share price has decreased by 7.73% and in the last one year, it has increased by 7.46%. The 52-week low for Max Healthcare Institute share price was Rs. 933.8 and 52-week high was Rs. 1314.3.
Max Healthcare Institute Limited is an India-based healthcare company with a market capitalisation of Rs. 35,729.35 crore as of April 5, 2022. It owns and operates hospital chains across Delhi, National Capital Region (NCR), North India, and Mumbai. The company was incorporated on June 18, 2001, and its revenue touched Rs. 2,505 crore in the financial year 2021-22. Max Healthcare shares are listed on the Bombay Stock Exchange (BSE) as well as the National Stock Exchange (NSE) under the number 543220 and scrip code MAXHEALTH, respectively.
Max Healthcare Limited is an Indian company that runs a chain of hospitals that specialise in providing treatment for cancer, oncology, neurosciences, cardiac sciences, orthopaedics, liver transplant, kidney transplant, bone marrow transplant, nephrology, and laparoscopic surgery, among others. The company also provides pathology and diagnostic services to its patients through a variety of channels, including self-owned and third-party diagnostic centres. The majority of Max Healthcare hospitals are located in Delhi, the National Capital Region (NCR), northern parts of India, and western Mumbai.
The company was founded in 2000 and its first hospital was opened in the same year in South Delhi’s Panchsheel Park. It opened two more hospitals in 2002 in Northwest Delhi and Eastern Delhi. In 2011, Max Healthcare Limited signed a public-private partnership agreement with the government of Punjab to set up two hospitals in Mohali and Bathinda. It witnessed acquisitions and mergers with several hospitals during the process, including Pushpanjali Crosslay Hospital in Vaishali, Saket City Hospital in Saket, Radiant Lifecare, and the iconic Nanavati Hospital in Mumbai, and soon became the second-largest healthcare company in India in terms of revenues. The total number of employees of this company stood at 3,783 in 2020. The Managing Director of the company, Abhay Soi, holds 23.1% shares in the company, other promoters 37.54%, FII investors 16.67%, public investors 6.97%, and 15.58% are invested in mutual funds.
As of April 5, 2022, Max Healthcare’s share price closed at Rs. 369.40 at the NSE. The 52-week high for Max Health share is Rs. 458.05 and the 52-week low is Rs. 212.00. Max Healthcare shares have provided one-year returns of 61.06%.
Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code :07730), BSE Ltd (Member Code :103) and Member of Multi Commodity Exchange of India Ltd. (Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.
Max Healthcare Institute share price as on 27 Feb 2026 is Rs. 1091.95. Over the past 6 months, the Max Healthcare Institute share price has decreased by 7.73% and in the last one year, it has increased by 7.46%. The 52-week low for Max Healthcare Institute share price was Rs. 933.8 and 52-week high was Rs. 1314.3.
